Rosacea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Females or males aged 18-55 years; 2) Patients diagnosed with rosacea according to the 2017 edition of the International Diagnostic Criteria for Rosacea; and patients with rosacea predominantly of the erythematous capillary dilatation type according to the 2002 International Committee of Rosacea Specialists typology; 3) Patients who have received Intense Pulsed Light (IPL) treatment or topical moisturizing agents in our clinic; 4) Subjects who have undergone retrospective collection of clinical data and are available to provide portraits; 5) Understanding and willingness to participate in this clinical study and voluntarily signing the informed consent form (all subjects were included).
Exclusion criteria
Exclusion criteria: 1) Presence of rosacea-associated pustules; 2) Lack of data related to the physical signs of rosacea (images or self-reported symptoms); 3) The presence of a serious systemic disease that may affect the results of the test; 4) Pregnant or breastfeeding women; 5) Have other facial skin disorders (e.g., psoriasis, eczema, infections); 6) Unable/unwilling to follow up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinician's Erythema Assessment (CEA); | — |
Secondary
| Measure | Time frame |
|---|---|
| Physician Visual Assessment Score;Pore;sebum;skin tone;Hydration;Elasticity;Melanin;Patient attitudes and choices about treatment; | — |
Countries
China
Contacts
Xiangya hospital, Central south university